The Bekaert Sa (BEKAY) Lifted to “Buy” at ING Group

The Bekaert Sa (BEKAY) Lifted to “Buy” at ING Group

Bekaert Sa (OTC:BEKAY) was upgraded by ING Group from a “hold” rating to a “buy” rating in a research report issued on Monday, StockTargetPrices.com reports. Bekaert Sa (OTC:BEKAY) traded up 0.000% during mid-day trading on Monday, reaching $4.347. The stock’s 50 day moving average price is $4.35 and its 200 day moving average price is $4.35. The stock has a market capitalization of $2623.33 billion and a price-to-earnings ratio of 27.883. Bekaert Sa has a 1-year low of $4.35 and a 1-year high of $4.52.

The Insider Selling: Intact Financial Co. (IFC) Insider Sells 1,738 Shares of Stock

The Insider Selling: Intact Financial Co. (IFC) Insider Sells 1,738 Shares of Stock

Intact Financial Co. (TSE:IFC) insider Mark Alan Tullis sold 1,738 shares of the firm’s stock in a transaction on Monday, March 6th. The shares were sold at an average price of C$95.49, for a total transaction of C$165,961.62. Mark Alan Tullis also recently made the following trade(s): Intact Financial Co. (TSE:IFC) traded up 0.46% during mid-day trading on Monday, hitting $95.38. 149,161 shares of the stock were exchanged. The stock has a market capitalization of $12.50 billion and a PE ratio of 24.02. The company has a 50-day moving average…

The Robert L. Mccormick Sells 10,951 Shares of Douglas Dynamics Inc (PLOW) Stock

The Robert L. Mccormick Sells 10,951 Shares of Douglas Dynamics Inc (PLOW) Stock

Douglas Dynamics Inc (NYSE:PLOW) CFO Robert L. Mccormick sold 10,951 shares of the stock in a transaction that occurred on Monday, March 6th. The shares were sold at an average price of $32.47, for a total transaction of $355,578.97. Following the completion of the transaction, the chief financial officer now owns 142,214 shares in the company, valued at $4,617,688.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Douglas Dynamics Inc (NYSE:PLOW) traded down 0.91% during midday trading on…

The Franklin Myers Acquires 1,500 Shares of Comfort Systems USA, Inc. (FIX) Stock

The Franklin Myers Acquires 1,500 Shares of Comfort Systems USA, Inc. (FIX) Stock

Comfort Systems USA, Inc. (NYSE:FIX) Chairman Franklin Myers purchased 1,500 shares of the stock in a transaction dated Monday, March 6th. The shares were purchased at an average cost of $36.83 per share, for a total transaction of $55,245.00. Following the transaction, the chairman now owns 191,500 shares in the company, valued at approximately $7,052,945. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Franklin Myers also recently made the following trade(s): Comfort Systems USA, Inc. (NYSE:FIX) traded down 1.73% on…

The Insider Selling: Bright Horizons Family Solutions Inc (BFAM) COO Sells 2,000 Shares of Stock

The Insider Selling: Bright Horizons Family Solutions Inc (BFAM) COO Sells 2,000 Shares of Stock

Bright Horizons Family Solutions Inc (NYSE:BFAM) COO Mary Lou Burke sold 2,000 shares of the stock in a transaction on Monday, March 6th. The stock was sold at an average price of $69.16, for a total value of $138,320.00. Following the sale, the chief operating officer now directly owns 34,012 shares of the company’s stock, valued at $2,352,269.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Bright Horizons Family Solutions Inc (NYSE:BFAM) traded down 0.11% on Monday,…

The Kite Pharma Inc (KITE) Shares Gap Up on Analyst Upgrade

The Kite Pharma Inc (KITE) Shares Gap Up  on Analyst Upgrade

Kite Pharma Inc (NASDAQ:KITE) shares gapped up before the market opened on Monday after RBC Capital Markets raised their price target on the stock from $85.00 to $95.00. The stock had previously closed at $70.88, but opened at $72.53. RBC Capital Markets currently has an outperform rating on the stock. Kite Pharma shares last traded at $73.90, with a volume of 2,107,068 shares traded. A number of other research analysts also recently issued reports on KITE. Jefferies Group LLC reiterated a “buy” rating on shares of Kite Pharma in a…

The Roth Capital Initiates Coverage on Limbach Holdings, Inc. (LMB)

The Roth Capital Initiates Coverage on Limbach Holdings, Inc. (LMB)

Equities researchers at Roth Capital started coverage on shares of Limbach Holdings, Inc. (NDAQ:LMB) in a research report issued on Monday, StockTargetPrices.com reports. The brokerage set a “buy” rating and a $17.50 price target on the stock. Limbach Holdings (NDAQ:LMB) traded up 1.21% on Monday, reaching $14.27. The company’s stock had a trading volume of 29,330 shares. The stock’s market cap is $84.58 million. The company’s 50 day moving average price is $13.98 and its 200-day moving average price is $13.28. Limbach Holdings has a 12-month low of $6.75 and…

The Peter A. Appel Buys 394,400 Shares of Ideal Power Inc. (IPWR) Stock

The Peter A. Appel Buys 394,400 Shares of Ideal Power Inc. (IPWR) Stock

Ideal Power Inc. (NASDAQ:IPWR) major shareholder Peter A. Appel acquired 394,400 shares of the firm’s stock in a transaction on Friday, March 3rd. The stock was purchased at an average price of $2.54 per share, for a total transaction of $1,001,776.00. Following the transaction, the insider now directly owns 1,233,177 shares of the company’s stock, valued at approximately $3,132,269.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a…

The BSB Bancorp Inc (BLMT) Insider Christopher Y. Downs Sells 3,800 Shares of Stock

The BSB Bancorp Inc (BLMT) Insider Christopher Y. Downs Sells 3,800 Shares of Stock

BSB Bancorp Inc (NASDAQ:BLMT) insider Christopher Y. Downs sold 3,800 shares of the business’s stock in a transaction dated Wednesday, March 1st. The stock was sold at an average price of $28.00, for a total value of $106,400.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Shares of BSB Bancorp Inc (NASDAQ:BLMT) traded down 0.89% during trading on Monday, hitting $27.70. The stock had a trading volume of 4,496 shares. The company has a market cap of $241.27 million, a P/E…

The Broadcom Ltd (AVGO) Insider Kirsten M. Spears Sells 520 Shares

The Broadcom Ltd (AVGO) Insider Kirsten M. Spears Sells 520 Shares

Broadcom Ltd (NASDAQ:AVGO) insider Kirsten M. Spears sold 520 shares of the firm’s stock in a transaction that occurred on Thursday, March 2nd. The stock was sold at an average price of $220.10, for a total transaction of $114,452.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Kirsten M. Spears also recently made the following trade(s): Shares of Broadcom Ltd (NASDAQ:AVGO) traded down 0.17% during midday trading on Monday, hitting $217.94. 2,236,869 shares of the stock were exchanged….

The Interface, Inc. (TILE) Director Daniel T. Hendrix Sells 6,000 Shares of Stock

The Interface, Inc. (TILE) Director Daniel T. Hendrix Sells 6,000 Shares of Stock

Interface, Inc. (NASDAQ:TILE) Director Daniel T. Hendrix sold 6,000 shares of the stock in a transaction that occurred on Friday, March 3rd. The shares were sold at an average price of $19.75, for a total transaction of $118,500.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Daniel T. Hendrix also recently made the following trade(s): Interface, Inc. (NASDAQ:TILE) traded down 1.28% during midday trading on Monday, reaching $19.35. 446,860 shares of the company were exchanged. Interface, Inc….

The Cosmos Hldgs Inc Com (COSM) CEO Grigorios Siokas Sells 1,366,733 Shares of Stock

The Cosmos Hldgs Inc Com (COSM) CEO Grigorios Siokas Sells 1,366,733 Shares of Stock

Cosmos Hldgs Inc Com (NASDAQ:COSM) CEO Grigorios Siokas sold 1,366,733 shares of the company’s stock in a transaction dated Thursday, March 2nd. The stock was sold at an average price of $0.09, for a total transaction of $123,005.97. Following the completion of the sale, the chief executive officer now owns 99,047,666 shares in the company, valued at approximately $8,914,289.94. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Grigorios Siokas also recently made the following trade(s): Cosmos Hldgs Inc Com (NASDAQ:COSM) remained flat…

The HubSpot Inc (HUBS) Insider Hunter Madeley Sells 1,000 Shares of Stock

The HubSpot Inc (HUBS) Insider Hunter Madeley Sells 1,000 Shares of Stock

HubSpot Inc (NYSE:HUBS) insider Hunter Madeley sold 1,000 shares of the stock in a transaction that occurred on Thursday, March 2nd. The shares were sold at an average price of $60.30, for a total transaction of $60,300.00. Following the transaction, the insider now directly owns 102,920 shares of the company’s stock, valued at $6,206,076. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Hunter Madeley also recently made the following trade(s): HubSpot Inc (NYSE:HUBS) traded down 1.20% during mid-day trading on…

The Expedia Inc (EXPE) Upgraded by Citigroup Inc to “Neutral”

The Expedia Inc (EXPE) Upgraded by Citigroup Inc to “Neutral”

Citigroup Inc upgraded shares of Expedia Inc (NASDAQ:EXPE) from a sell rating to a neutral rating in a report published on Friday morning. The firm currently has $130.00 target price on the online travel company’s stock. Other equities research analysts have also recently issued research reports about the stock. Evercore ISI reissued a hold rating and issued a $125.00 price target on shares of Expedia in a research note on Friday, February 10th. Needham & Company LLC reissued a buy rating on shares of Expedia in a research note on…

The Cara Therapeutics’ (CARA) “Overweight” Rating Reaffirmed at Piper Jaffray Companies

The Cara Therapeutics’ (CARA) “Overweight” Rating Reaffirmed at Piper Jaffray Companies

Piper Jaffray Companies reissued their overweight rating on shares of Cara Therapeutics Inc (NASDAQ:CARA) in a research report released on Friday morning. The firm currently has a $23.00 target price on the biopharmaceutical company’s stock. Several other research firms have also recently weighed in on CARA. HC Wainwright restated a buy rating and set a $22.00 price objective (up previously from $20.00) on shares of Cara Therapeutics in a research report on Tuesday, January 31st. Vetr upgraded shares of Cara Therapeutics from a sell rating to a strong-buy rating and…

The JD.Com Inc (JD) Receives Market Perform Rating from Cowen and Company

The JD.Com Inc (JD) Receives Market Perform Rating from Cowen and Company

Cowen and Company reaffirmed their market perform rating on shares of JD.Com Inc (NASDAQ:JD) in a report issued on Friday. Cowen and Company currently has a $30.00 price target on the stock. Other equities analysts also recently issued reports about the company. Vetr downgraded JD.Com from a strong-buy rating to a hold rating and set a $26.86 price objective for the company. in a research report on Tuesday, November 15th. Sanford C. Bernstein assumed coverage on JD.Com in a research report on Wednesday, January 11th. They set an underperform rating…

The Casella Waste Systems Inc. (CWST) Receives Neutral Rating from Wedbush

The Casella Waste Systems Inc. (CWST) Receives Neutral Rating from Wedbush

Wedbush reaffirmed their neutral rating on shares of Casella Waste Systems Inc. (NASDAQ:CWST) in a report released on Friday morning. The brokerage currently has a $13.00 target price on the stock, up from their previous target price of $11.00. A number of other equities research analysts also recently weighed in on CWST. Zacks Investment Research downgraded shares of Casella Waste Systems from a buy rating to a hold rating in a research report on Monday, November 28th. Stifel Nicolaus reiterated a buy rating and issued a $16.00 price target (up…

The BioCryst Pharmaceuticals, Inc. (BCRX) Stake Owned by D. E. SHAW & COMPANY , L.P.

The BioCryst Pharmaceuticals, Inc. (BCRX) Stake Owned by   D. E. SHAW & COMPANY , L.P.

D. E. SHAW & COMPANY , L.P. disclosed that they own 5% of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Monday, March 6th. The investor owns 3,707,857 shares of the stock valued at about $28,921,285. The reporting parties listed on the disclosure included D E Shaw & Co, LP and David E Shaw. The disclosure is available through the SEC website at this link. Other institutional investors have also recently bought and sold shares of the company….

The Autodesk, Inc. (ADSK) Given Sector Perform Rating at RBC Capital Markets

The Autodesk, Inc. (ADSK) Given Sector Perform Rating at RBC Capital Markets

RBC Capital Markets reiterated their sector perform rating on shares of Autodesk, Inc. (NASDAQ:ADSK) in a report published on Friday morning. The brokerage currently has a $87.00 target price on the software company’s stock, up from their prior target price of $84.00. A number of other equities research analysts have also weighed in on ADSK. Royal Bank of Canada boosted their price objective on shares of Autodesk from $70.00 to $71.00 and gave the company a sector perform rating in a report on Wednesday, November 30th. Zacks Investment Research lowered…

The Goldcorp Inc. (G) Insider Wade William Bristol Sells 1,537 Shares of Stock

The Goldcorp Inc. (G) Insider Wade William Bristol Sells 1,537 Shares of Stock

Goldcorp Inc. (TSE:G) (NYSE:GG) insider Wade William Bristol sold 1,537 shares of the business’s stock in a transaction on Friday, March 3rd. The stock was sold at an average price of C$14.89, for a total value of C$22,885.93. Goldcorp Inc. (TSE:G) traded down 0.89% during trading on Monday, reaching $20.07. The company had a trading volume of 9,711,700 shares. The firm has a market capitalization of $17.14 billion and a price-to-earnings ratio of 105.63. The stock has a 50 day moving average price of $20.99 and a 200 day moving…